GO:0097154 | GABAergic neuron differentiation | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:2000977 | regulation of forebrain neuron differentiation | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0060872 | semicircular canal development | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0019865 | immunoglobulin binding | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0021514 | ventral spinal cord interneuron differentiation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0035854 | eosinophil fate commitment | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0070345 | negative regulation of fat cell proliferation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:0021533 | cell differentiation in hindbrain | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0016576 | histone dephosphorylation | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0033093 | Weibel-Palade body | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0007599 | hemostasis | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0035065 | regulation of histone acetylation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0000125 | PCAF complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0030914 | STAGA complex | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 2 | 6 |
GO:0045650 | negative regulation of macrophage differentiation | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0001655 | urogenital system development | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0031091 | platelet alpha granule | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0021954 | central nervous system neuron development | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0045746 | negative regulation of Notch signaling pathway | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0008134 | transcription factor binding | 6.46e-03 | 1.00e+00 | 3.961 | 2 | 10 | 209 |
GO:0001709 | cell fate determination | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0048568 | embryonic organ development | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0033276 | transcription factor TFTC complex | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 3 | 11 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 13 |
GO:0007597 | blood coagulation, intrinsic pathway | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 13 |
GO:0060216 | definitive hemopoiesis | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0031589 | cell-substrate adhesion | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0048873 | homeostasis of number of cells within a tissue | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 14 |
GO:0001158 | enhancer sequence-specific DNA binding | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0006352 | DNA-templated transcription, initiation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 3 | 15 |
GO:0070742 | C2H2 zinc finger domain binding | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0050766 | positive regulation of phagocytosis | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0003682 | chromatin binding | 9.29e-03 | 1.00e+00 | 3.691 | 2 | 15 | 252 |
GO:1903506 | regulation of nucleic acid-templated transcription | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 2 | 16 |
GO:0045648 | positive regulation of erythrocyte differentiation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 17 |
GO:0007369 | gastrulation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 17 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0005669 | transcription factor TFIID complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0045739 | positive regulation of DNA repair | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0001892 | embryonic placenta development | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 20 |
GO:0006909 | phagocytosis | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 22 |
GO:0021983 | pituitary gland development | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 22 |
GO:0001890 | placenta development | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 26 |
GO:0007596 | blood coagulation | 1.64e-02 | 1.00e+00 | 3.263 | 2 | 13 | 339 |
GO:0043966 | histone H3 acetylation | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 4 | 28 |
GO:0045599 | negative regulation of fat cell differentiation | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 2 | 29 |
GO:0010212 | response to ionizing radiation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 3 | 30 |
GO:0004402 | histone acetyltransferase activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 3 | 30 |
GO:0048469 | cell maturation | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0035019 | somatic stem cell maintenance | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 3 | 32 |
GO:0031093 | platelet alpha granule lumen | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 35 |
GO:0042472 | inner ear morphogenesis | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 1 | 37 |
GO:0001948 | glycoprotein binding | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 1 | 37 |
GO:0009611 | response to wounding | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 2 | 41 |
GO:0051087 | chaperone binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 45 |
GO:0005518 | collagen binding | 2.85e-02 | 1.00e+00 | 5.114 | 1 | 2 | 47 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.88e-02 | 1.00e+00 | 2.836 | 2 | 29 | 456 |
GO:0004725 | protein tyrosine phosphatase activity | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 1 | 49 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 4 | 49 |
GO:0002020 | protease binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 50 |
GO:0006302 | double-strand break repair | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 5 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 8 | 52 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 3.69e-02 | 1.00e+00 | 4.738 | 1 | 5 | 61 |
GO:0002576 | platelet degranulation | 3.75e-02 | 1.00e+00 | 4.714 | 1 | 3 | 62 |
GO:0047485 | protein N-terminus binding | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 6 | 65 |
GO:0009653 | anatomical structure morphogenesis | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 1 | 65 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 4.05e-02 | 1.00e+00 | 4.602 | 1 | 5 | 67 |
GO:0005178 | integrin binding | 4.11e-02 | 1.00e+00 | 4.581 | 1 | 3 | 68 |
GO:0006325 | chromatin organization | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 4 | 70 |
GO:0001889 | liver development | 4.29e-02 | 1.00e+00 | 4.519 | 1 | 4 | 71 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 4.53e-02 | 1.00e+00 | 2.484 | 2 | 22 | 582 |
GO:0045766 | positive regulation of angiogenesis | 4.70e-02 | 1.00e+00 | 4.383 | 1 | 4 | 78 |
GO:0051260 | protein homooligomerization | 5.23e-02 | 1.00e+00 | 4.225 | 1 | 2 | 87 |
GO:0007601 | visual perception | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 2 | 97 |
GO:0031012 | extracellular matrix | 6.40e-02 | 1.00e+00 | 3.927 | 1 | 4 | 107 |
GO:0005578 | proteinaceous extracellular matrix | 6.86e-02 | 1.00e+00 | 3.823 | 1 | 4 | 115 |
GO:0000398 | mRNA splicing, via spliceosome | 7.61e-02 | 1.00e+00 | 3.668 | 1 | 15 | 128 |
GO:0009897 | external side of plasma membrane | 7.79e-02 | 1.00e+00 | 3.635 | 1 | 3 | 131 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 7.84e-02 | 1.00e+00 | 3.624 | 1 | 4 | 132 |
GO:0030168 | platelet activation | 8.36e-02 | 1.00e+00 | 3.529 | 1 | 5 | 141 |
GO:0005667 | transcription factor complex | 8.70e-02 | 1.00e+00 | 3.469 | 1 | 8 | 147 |
GO:0001701 | in utero embryonic development | 9.10e-02 | 1.00e+00 | 3.402 | 1 | 7 | 154 |
GO:0005654 | nucleoplasm | 9.46e-02 | 1.00e+00 | 1.894 | 2 | 68 | 876 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.50e-02 | 1.00e+00 | 3.338 | 1 | 18 | 161 |
GO:0005634 | nucleus | 9.92e-02 | 1.00e+00 | 1.004 | 4 | 158 | 3246 |
GO:0046872 | metal ion binding | 1.06e-01 | 1.00e+00 | 1.801 | 2 | 24 | 934 |
GO:0003677 | DNA binding | 1.08e-01 | 1.00e+00 | 1.781 | 2 | 52 | 947 |
GO:0003713 | transcription coactivator activity | 1.08e-01 | 1.00e+00 | 3.145 | 1 | 21 | 184 |
GO:0043234 | protein complex | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 13 | 210 |
GO:0007275 | multicellular organismal development | 1.25e-01 | 1.00e+00 | 2.927 | 1 | 9 | 214 |
GO:0030198 | extracellular matrix organization | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 7 | 221 |
GO:0006351 | transcription, DNA-templated | 1.35e-01 | 1.00e+00 | 1.597 | 2 | 47 | 1076 |
GO:0007155 | cell adhesion | 1.41e-01 | 1.00e+00 | 2.738 | 1 | 8 | 244 |
GO:0046982 | protein heterodimerization activity | 1.52e-01 | 1.00e+00 | 2.619 | 1 | 11 | 265 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.92e-01 | 1.00e+00 | 2.255 | 1 | 23 | 341 |
GO:0042802 | identical protein binding | 1.99e-01 | 1.00e+00 | 2.201 | 1 | 15 | 354 |
GO:0005515 | protein binding | 2.11e-01 | 1.00e+00 | 0.659 | 4 | 198 | 4124 |
GO:0005783 | endoplasmic reticulum | 2.12e-01 | 1.00e+00 | 2.095 | 1 | 12 | 381 |
GO:0042803 | protein homodimerization activity | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 13 | 428 |
GO:0016032 | viral process | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 30 | 428 |
GO:0010467 | gene expression | 2.87e-01 | 1.00e+00 | 1.605 | 1 | 49 | 535 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.36e-01 | 1.00e+00 | 1.338 | 1 | 29 | 644 |
GO:0005576 | extracellular region | 3.44e-01 | 1.00e+00 | 1.296 | 1 | 15 | 663 |
GO:0006355 | regulation of transcription, DNA-templated | 3.66e-01 | 1.00e+00 | 1.187 | 1 | 31 | 715 |
GO:0008270 | zinc ion binding | 3.71e-01 | 1.00e+00 | 1.163 | 1 | 39 | 727 |
GO:0044822 | poly(A) RNA binding | 4.01e-01 | 1.00e+00 | 1.026 | 1 | 45 | 799 |
GO:0005730 | nucleolus | 5.50e-01 | 1.00e+00 | 0.419 | 1 | 74 | 1217 |
GO:0070062 | extracellular vesicular exosome | 6.69e-01 | 1.00e+00 | -0.012 | 1 | 51 | 1641 |
GO:0005737 | cytoplasm | 8.48e-01 | 1.00e+00 | -0.694 | 1 | 127 | 2633 |